AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 296: F382-F389, 2009. First published November 19, 2008; doi:10.1152/ajprenal.90543.2008
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/F382    most recent
90543.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. M.
Right arrow Articles by Schnermann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. M.
Right arrow Articles by Schnermann, J.

Dense-core vesicle proteins IA-2 and IA-2β affect renin synthesis and secretion through the β-adrenergic pathway

Soo Mi Kim,1 Franziska Theilig,2 Yan Qin,1 Tao Cai,3 Diane Mizel,1 Robert Faulhaber-Walter,1 Hiroki Hirai,3 Sebastian Bachmann,2 Josephine P. Briggs,4 Abner L. Notkins,2 and Jurgen Schnermann1

1National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda; 2Institute of Anatomy, Charite, Berlin, Germany; and 3National Institute of Dental and Craniofacial Research, National Institute of Child Health and Human Development, and 4National Center of Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland

Submitted 15 September 2008 ; accepted in final form 13 November 2008

IA-2 and IA-2β, major autoantigens in type 1 diabetes, are transmembrane proteins in dense-core vesicles, and their expression influences the secretion of hormones and neurotransmitters. The present experiments were performed to examine whether IA-2 and IA-2β modulate the release of renin from dense-core vesicles of juxtaglomerular granular cells in the kidney. Plasma renin concentration (PRC; ng angiotensin I·ml–1·h–1) was significantly reduced in mice with null mutations in IA-2, IA-2β, or both IA-2 and IA-2β compared with wild-type mice (876 ± 113, 962 ± 130, and 596 ± 82 vs. 1,367 ± 93; P < 0.01, P < 0.02, and P < 0.001). Renin mRNA levels were reduced to 26.4 ± 5.1, 39 ± 5.4, and 35.3 ± 5.5% of wild-type in IA-2–/–, IA-2β–/–, and IA-2/IA-2β–/– mice. Plasma aldosterone levels were not significantly different among genotypes. The regulation of PRC by furosemide and salt intake, and of aldosterone by salt intake, was maintained in all genotypes. IA-2 and IA-2β expression did not colocalize with renin but showed overlapping immunoreactivity with tyrosine hydroxylase. While propranolol reduced PRC in wild-type mice, it had no effect on PRC in IA-2/ IA-2β–/– mice. Renal tyrosine hydroxylase mRNA and immunoreactivity were reduced in IA-2/IA-2β–/– mice as was the urinary excretion of catecholamines. We conclude that IA-2 and IA-2β are required to maintain normal levels of renin expression and renin release, most likely by permitting normal rates of catecholamine release from sympathetic nerve terminals.

knockout mice; renin mRNA; propranolol; blood pressure; heart rate; salt intake



Address for reprint requests and other correspondence: J. Schnermann, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bldg. 10, Rm. 4D51, 10 Center Dr.-MSC 1370, Bethesda, MD 20892 (e-mail: jurgens{at}intra.niddk.nih.gov)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.